Orchestra BioMed Holdings, Inc. Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest
Orchestra BioMed Holdings, Inc. (OBIO) reported Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest of -$92.33 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Income Statement
us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest · last filed 2021-08-16
- Orchestra BioMed Holdings, Inc. net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2021-06-30 was -$92.33K.
| Period end | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 1 month | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 6 month |
|---|---|---|---|
| 2021-06-30 | -$92.33K 10-Q · filed 2021-08-16 | -$200.33K 10-Q · filed 2021-08-16 | |
| 2020-06-30 | -$15.21K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |